ISSN 2407-2230 | E-ISSN 1907-3062 | Universa Medicina content is searchable on DOAJ, Google Scholar, and OAI

Decreased adiponectin level in adults with central obesity and low 25-hydroxy vitamin D level

Pusparini Pusparini, Lie Tanu Merijanti, Alvina Lesmana, Meiyanti Meiyanti
Submission date: Monday, 29 May 2017
Published date: Thursday, 16 November 2017


Vitamin D insufficiency is associated with obesity and central obesity, which is in turn associated with the accumulation of visceral fat. Visceral fat secretes adiponectin which has a role in the pathogenesis of the metabolic syndrome, diabetes mellitus and cerebrovascular disease. The aim of this study was to determine the relationship between serum 25-hydroxy vitamin D [25(OH)D] level and adiponectin level in adults with central obesity.

This study was a cross sectional study with 80 subjects with central obesity and 80 healthy subjects as controls. The age of the subjects ranged from 55 to 65 years. The data collection included anthropometry and blood biochemistry (lipid profile, fasting blood glucose, 25(OH)D, and adiponectin). The data were analyzed using independent t test with p <0.05.

Mean waist circumference and 25(OH)D level in the central obesity group were 94.9 ± 7.8 cm and 14.3 ± 6.6 ng/mL, respectively, and in the control group 72.4 ± 5.0 cm and 19.2 ± 8.6 ng/mL respectively. There were significant differences in adiponectin level between the central obesity group and the control group at the 25(OH)D level of <20 ng/mL (p=0.001), but no significant differences between the two groups at the 25(OH)D level of ³20 ng/mL (p=0.538).

The central obesity subgroup with 25(OH)D level of <20 ng/mL have lower adiponectin levels compared with the control group. This study demonstrates the role of adiponectin as a link between insulin resistance and vitamin D status in adults.


Vitamin D deficiency; central obesity; adiponectin; adult

Full Text:



James WP. The epidemiology of obesity: the size of the problem. J Intern Med 2008;263:336-52.

Zhang P, Wang R. Gao C, et al. Prevalence of central obesity among adults with normal BMI and its association with metabolic diseases in northeast China. Plos One 2016;11:e0160402. Doi: 10.1371/jounal.pone.0160402.

Singla P, Bardolol A, Parkash AA. Metabolic effects of obesity: a review. World J Diab 2010;1: 76-88.

Zhang J, Kho P, Kuliesh OV, et al. Adiponectin, resistin and leptin : possible markers of metabolic syndrome. Endocrinol Metab Syndr 2015;4:212. Doi:10.4172/2161-1017.1000212.

Huang FY, del Rio Navarro BE, Perez-Ontiveros JA, et al. Effect of six month lifestyle intervention on adiponectin, resistin and soluble tumor necrosis factor–á receptors in obese adolescents. Endocr J Adv Pub 2014. Doi: 10.1507/endocrj. EJ14-0157.

Hamid Mehmood ZTN, Papandreaou D. An updated mini review of vitamin D and obesity: adipogenesis and inflammation state. J Med Sci 2016;15:526-32.

Jaramillo PL. The role of adiponectin in cardiometabolic diseases: effects of nutritional interventions. J Nutr 2016;146 :422S-6S.

Bidulescu A, Morris AA, Stoyanova N, et al. Association between vitamin D and adiponectin and its relationship with body mass index: the meta health study. Front Pub Health 2014;2:193. Doi.10.3389/fpubh.2014.00193.

Holick M. Vitamin D deficiency. N Engl J Med 2007;357:266-81.

Setiati S. Pengaruh sinar ultraviolet B matahari terhadap konsentrasi vitamin D dan hormone parathyroid pada perempuan usia lanjut Indonesia. J Kes Masy Nas 2008;2:147-53.

Green TJ, Skeaff CM, Rockell JEP, et al. Vitamin D status and its association with parathyroid hormone concentration in women of child bearing age living in Jakarta and Kuala Lumpur. EJCN 2008;62:373-8.

Foong MM, Bulgiba A. High prevalence of vitamin D insufficiency and its association with obesity and metabolic syndrome among Malay adults in Kuala Lumpur, Malaysia. BMC Public Health 2011;11:735. http://www.biomedcentral. com/1471-2458/11/735.

Friedenreich CM, Biel RK, Lau DCW, et al. Case control study of the metabolic syndrome and metabolic risk factors for endometrial cancer. Epidemiol Biomarkers Prev 2011;20:2384-95.

Seton M, Jackson V, Lesser KE, et al. Low 25-hydroxyvitamin D and osteopenia are prevalent in persons > or = 55 yr with fracture at any site: a prospective, obeservational study of persons fracturing in the community. J Clin Densitom 2005; 8:454-60.

Enko D, Kriegshauser, Stolba R, et al. Method evaluation study of a new generation of vitamin D assays. Biochem Med 2015;25:203-12.

Liu D, Schuster T, Baumann M, et al. Comparison of immunoassays for the selective measurement of human high molecular weight adiponectin. Clin Chem 2009;55:568-72.

Al-Dabhani K, Tsilidis KK, Murphy N, et al. Prevalence of vitamin D deficiency and association with metabolic syndrome in a Qatari population. Nutrition & Diabetes 2017;7:e263. Doi: 10.1038/nutd.2017.14.

Shafinaz ID, Moy FM. Vitamin D level and its association with adiposity among multi ethnic adults in Kuala Lumpur, Malaysia: a cross sectional study. BMC Public Health 2016;16:232. Doi: 10.1186/s12889-016-2924-1.

Zhen DH, Liu LJ, Guan CH, et al. High prevalence of vitamin D deficiency among middle-age and elderly individuals in northwestern China: Its relationship to osteoporosis and lifestyle factors. J Bone 2015;71. 024.

Johnson LK, Hofso D, Aasheim ET, et al. Impact of gender on vitamin D deficiency in morbidly obese patients : a cross sectional study. Eur J Clin Nutr 2012;66:83-90.

Oommen A, Al Zahrani IH. Association of obesity with vitamin D deficiency and the clinical implications. Int J Res Med Sci 2015;3:3262-5.

Tosunbayraktar G, Bas M, Kut A, et al. Low serum 25(OH)D levels are associated to higher BMI and metabolic syndrome parameter in adult subjects in Turkey. Afri Health Sci 2015;15:1161-9.

Norman AW. Mini review: vitamin D receptor new assignments for an already busy receptor. Endocrinology 2006;147:5542-8. doi: 10.1210/en.2006-0946.

Liu E, Meigs JB, Pittas AG, et al. Plasma 25-hydroxyvitamin D is associated with markers of the insulin resistant phenotype in nondiabetic adults. J Nutr 2009;139:329-34.

Lee S, Lee DK, Choi E, et al. Identification of functional vitamin D response element in the murrine Insig-2 promoter and its potential role in the differentiation of 3T3-L1 preadipocytes. Mol Endocrinol 2005;19:399-408.

Wimalawansa SJ. Vitamin D deficiency is a surrogate marker for visceral fat content, metabolic syndrome, type 2 diabetes, and future complications. J Diabetes Metab Disord Control 2016;3:00059. Doi: 10.15406/jdmdc.2016.03.00059.

Si EK, Yea EK, Kyong HY, et al. Plasma adiponectin levels in elderly patients with prediabetes. Endocrinol Metab 2015;30:326-33. Doi: 10.3803/EnM.2015.30.3.326.

Wang J, Li HX, Franco OH, et al. Adiponenctin and metabolic syndrome in the middle-aged and elderly Chinese. Obesity 2008;16:172-8. doi: 10.1038/oby2007.42.


  • There are currently no refbacks.

Copyright (c) 2017 Universa Medicina

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Creative Commons License
Universa Medicina by Faculty of Medicine, Trisakti University is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Based on a work at